Similar Papers

Paper Title
Journal
Date
Author
State of the art of surgery in advanced epithelial ovarian cancer
N.F Hacker
Annals of Oncology | VOL. 24
N.F HackerN.F Hacker
01 Dec 2013
Tumor biology and impact on timing of surgery in advanced epithelial ovarian cancer
Irina Tsibulak ... Christina Fotopoulou
International Journal of Gynecologic Cancer | VOL. 33
Irina Tsibulak, et. al.Irina Tsibulak ... Christina Fotopoulou
01 Oct 2023
#737 Complete cytoreduction rate differs according to the experience, competence and multidisciplinary team readily available at the hospital setting in patients with carcinomatosis peritonei due to advanced stage ovarian cancer
Murat Api ... Serkan Akis
International Journal of Gynecologic Cancer | VOL. 33
Murat Api, et. al.Murat Api ... Serkan Akis
01 Sep 2023
Robotic surgery in early and advanced ovarian cancer: Case selection for surgical staging and interval debulking surgery
Philippe Van Trappen ... Nele Claes
European Journal of Obstetrics & Gynecology and Reproductive Biology | VOL. 280
Philippe Van Trappen, et. al.Philippe Van Trappen ... Nele Claes
08 Nov 2022
View more papers

More From: Cochrane Clinical Answers

Paper Title
Journal
Date
Author
How does donor human milk compare with formula in preventing severe bowel disorders and associated morbidity and mortality in preterm, very preterm, or very low-birthweight infants when sufficient maternal milk is not available?
Sophia Kuperman ... Nai Ming Lai
Cochrane Clinical Answers | VOL. -
Sophia Kuperman, et. al.Sophia Kuperman ... Nai Ming Lai
17 Jan 2025
How do transvaginal permanent mesh and biological grafts compare with native-tissue repair for women with vaginal prolapse?
Natalia Cárdenas-Suárez
Cochrane Clinical Answers | VOL. -
Natalia Cárdenas-SuárezNatalia Cárdenas-Suárez
15 Jan 2025
For women at risk of preterm birth, what are the effects of prenatal magnesium sulfate on maternal outcomes and on infant outcomes extending into childhood?
Nai Ming Lai
Cochrane Clinical Answers | VOL. -
Nai Ming LaiNai Ming Lai
15 Jan 2025
How does the addition of immune checkpoint inhibitors (ICIs) to platinum-based chemotherapy compare with platinum-based chemotherapy alone as a first-line treatment for older adults with non-small cell lung cancer (NSCLC)?
Amin Sharifan
Cochrane Clinical Answers | VOL. -
Amin SharifanAmin Sharifan
13 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.